CVS Sees Little Risk In Medicare Rx; Utilization Would Offset Cash Declines
Executive Summary
A Medicare prescription drug benefit would shift only 2% of CVS prescriptions from cash to third-party coverage, CEO Tom Ryan told a July 30 analyst call
You may also be interested in...
Rx Reimportation Passes House; CBO Score May Keep It Out Of Medicare Rx
The Congressional Budget Office's determination that prescription drug reimportation would not provide any cost savings could help House/Senate Medicare conferees distance themselves from the House's positive vote on reimportation
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials